Documents Show Effort to Promote Unproven Drug New York Times, Oct 29, 2002
By MELODY PETERSEN

Marketing executives at Warner-Lambert urged their superiors to let them promote the epilepsy drug Neurontin for an unapproved use rather than perform the clinical studies needed to prove the medicine was safe for such patients, according to a corporate memorandum unsealed on Friday in federal court. [ This article gives detail into marketing techniques used by drug company Warner-Lambert to push drug on physicians and patients. - JC]